Annual Accounts Payable
$2.24 M
-$11.99 M-84.27%
December 31, 2023
Summary
- As of February 22, 2025, VRDN annual accounts payable is $2.24 million, with the most recent change of -$11.99 million (-84.27%) on December 31, 2023.
- During the last 3 years, VRDN annual accounts payable has risen by +$1.57 million (+234.18%).
- VRDN annual accounts payable is now -84.27% below its all-time high of $14.23 million, reached on December 31, 2022.
Performance
VRDN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.34 M
+$3.20 M+101.85%
September 30, 2024
Summary
- As of February 22, 2025, VRDN quarterly accounts payable is $6.34 million, with the most recent change of +$3.20 million (+101.85%) on September 30, 2024.
- Over the past year, VRDN quarterly accounts payable has increased by +$2.60 million (+69.69%).
- VRDN quarterly accounts payable is now -55.47% below its all-time high of $14.23 million, reached on December 31, 2022.
Performance
VRDN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VRDN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.3% | +69.7% |
| 3 y3 years | +234.2% | +69.7% |
| 5 y5 years | +292.1% | +69.7% |
VRDN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.3% | at low | -55.5% | +183.1% |
| 5 y | 5-year | -84.3% | +234.2% | -55.5% | +2631.9% |
| alltime | all time | -84.3% | +8285.8% | -55.5% | >+9999.0% |
Viridian Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.34 M(+101.8%) |
| Jun 2024 | - | $3.14 M(+17.3%) |
| Mar 2024 | - | $2.68 M(+19.5%) |
| Dec 2023 | $2.24 M(-84.3%) | $2.24 M(-40.1%) |
| Sep 2023 | - | $3.73 M(-9.6%) |
| Jun 2023 | - | $4.13 M(-47.5%) |
| Mar 2023 | - | $7.87 M(-44.7%) |
| Dec 2022 | $14.23 M(+511.2%) | $14.23 M(+17.1%) |
| Sep 2022 | - | $12.15 M(+199.2%) |
| Jun 2022 | - | $4.06 M(+60.0%) |
| Mar 2022 | - | $2.54 M(+9.0%) |
| Dec 2021 | $2.33 M(+247.6%) | $2.33 M(-37.6%) |
| Sep 2021 | - | $3.73 M(+56.0%) |
| Jun 2021 | - | $2.39 M(-29.3%) |
| Mar 2021 | - | $3.38 M(+405.1%) |
| Dec 2020 | $670.00 K(-38.9%) | $670.00 K(+188.8%) |
| Sep 2020 | - | $232.00 K(-18.9%) |
| Jun 2020 | - | $286.00 K(-82.4%) |
| Mar 2020 | - | $1.63 M(+48.6%) |
| Dec 2019 | $1.10 M | $1.10 M(-29.6%) |
| Sep 2019 | - | $1.56 M(+26.3%) |
| Jun 2019 | - | $1.23 M(+138.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $517.00 K(-9.5%) |
| Dec 2018 | $571.00 K(-37.0%) | $571.00 K(-52.7%) |
| Sep 2018 | - | $1.21 M(+161.6%) |
| Jun 2018 | - | $461.00 K(-39.3%) |
| Mar 2018 | - | $760.00 K(-16.1%) |
| Dec 2017 | $906.00 K(+469.8%) | $906.00 K(+121.5%) |
| Sep 2017 | - | $409.00 K(-35.3%) |
| Jun 2017 | - | $632.00 K(-43.8%) |
| Mar 2017 | - | $1.13 M(+607.5%) |
| Dec 2016 | $159.00 K(-34.3%) | $159.00 K(+211.8%) |
| Sep 2016 | - | $51.00 K(-45.7%) |
| Jun 2016 | - | $94.00 K(-7.8%) |
| Mar 2016 | - | $102.00 K(-57.9%) |
| Dec 2015 | $242.00 K(-5.1%) | $242.00 K(+24.1%) |
| Sep 2015 | - | $195.00 K(-41.3%) |
| Jun 2015 | - | $332.00 K(-13.5%) |
| Mar 2015 | - | $384.00 K(+50.6%) |
| Dec 2014 | $255.00 K(+155.0%) | $255.00 K(+6.9%) |
| Sep 2014 | - | $238.50 K(+42.2%) |
| Jun 2014 | - | $167.70 K(+975.0%) |
| Mar 2014 | - | $15.60 K(-84.4%) |
| Dec 2013 | $100.00 K(+274.5%) | $100.00 K |
| Dec 2012 | $26.70 K | - |
FAQ
- What is Viridian Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Viridian Therapeutics?
- What is Viridian Therapeutics annual accounts payable year-on-year change?
- What is Viridian Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly accounts payable year-on-year change?
What is Viridian Therapeutics annual accounts payable?
The current annual accounts payable of VRDN is $2.24 M
What is the all time high annual accounts payable for Viridian Therapeutics?
Viridian Therapeutics all-time high annual accounts payable is $14.23 M
What is Viridian Therapeutics annual accounts payable year-on-year change?
Over the past year, VRDN annual accounts payable has changed by -$11.99 M (-84.27%)
What is Viridian Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VRDN is $6.34 M
What is the all time high quarterly accounts payable for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly accounts payable is $14.23 M
What is Viridian Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VRDN quarterly accounts payable has changed by +$2.60 M (+69.69%)